Q4 2023 Holdings
Filed 2024-02-14 | 222 holdings | $5.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $1.5B | 19,991,024 | 27.2% |
| Glaukos Corp | NOTE 2.750% 6/1 | 377322AB8 | $414.9M | $271,452,000 | 7.7% |
| Viatris Inc(VTRS) | COM | 92556V106 | $215.1M | 19,863,484 | 4.0% |
| Invitae Corp | DEBT 4.500% 3/1 | 46185LAH6 | $187.0M | $217,766,000 | 3.5% |
| Natera Inc | NOTE 2.250% 5/0 | 632307AB0 | $172.4M | $101,042,000 | 3.2% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $149.4M | 8,888,901 | 2.8% |
| Centene Corp del(CNC) | COM | 15135B101 | $147.8M | 1,991,799 | 2.7% |
| Brookdale SR Living Inc | NOTE 2.000%10/1 | 112463AC8 | $133.2M | $145,955,000 | 2.5% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $123.5M | $116,954,000 | 2.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $118.2M | 896,719 | 2.2% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $114.0M | $132,598,000 | 2.1% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $102.9M | 11,246,820 | 1.9% |
| Owens & Minor Inc New(ACH) | COM | 690732102 | $100.8M | 5,229,779 | 1.9% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $99.2M | 13,607,940 | 1.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $94.3M | 2,584,376 | 1.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $93.6M | 2,630,292 | 1.7% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $93.4M | 5,788,024 | 1.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $88.6M | 3,090,073 | 1.6% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $86.1M | 14,793,264 | 1.6% |
| Merus N V | COM | N5749R100 | $83.0M | 3,019,901 | 1.5% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $77.1M | 16,941,357 | 1.4% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $76.4M | 5,312,733 | 1.4% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $67.4M | 2,105,509 | 1.2% |
| Hillevax Inc | COM | 43157M102 | $64.3M | 4,004,231 | 1.2% |
| Rayzebio Inc | COM | 75525N107 | $62.6M | 1,006,126 | 1.2% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $61.5M | 6,401,000 | 1.1% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $60.7M | 11,077,927 | 1.1% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $52.5M | 1,358,686 | 1.0% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $51.7M | 4,997,746 | 1.0% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $49.2M | 1,128,999 | 0.9% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $48.9M | 151,575 | 0.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $45.6M | 2,007,729 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $43.0M | 3,933,137 | 0.8% |
| Insulet Corp(PODD) | COM | 45784P101 | $38.8M | 178,920 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $33.5M | 822,813 | 0.6% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $30.0M | 3,488,808 | 0.6% |
| Docgo Inc(DCGO) | COM | 256086109 | $29.7M | 5,320,139 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $27.2M | 4,539,525 | 0.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $26.8M | 464,292 | 0.5% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $26.2M | 1,384,839 | 0.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $25.7M | 1,761,178 | 0.5% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $25.6M | 348,000 | 0.5% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $25.3M | 622,112 | 0.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $23.8M | 1,279,000 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $22.8M | 812,236 | 0.4% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $22.4M | 3,400,000 | 0.4% |
| Guardant Health Inc(GH) | COM | 40131M109 | $21.4M | 791,735 | 0.4% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $20.8M | 965,428 | 0.4% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $17.6M | 4,133,000 | 0.3% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $15.3M | 1,811,710 | 0.3% |